ECSP22046581A - Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento - Google Patents

Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento

Info

Publication number
ECSP22046581A
ECSP22046581A ECSENADI202246581A ECDI202246581A ECSP22046581A EC SP22046581 A ECSP22046581 A EC SP22046581A EC SENADI202246581 A ECSENADI202246581 A EC SENADI202246581A EC DI202246581 A ECDI202246581 A EC DI202246581A EC SP22046581 A ECSP22046581 A EC SP22046581A
Authority
EC
Ecuador
Prior art keywords
elatum
species
formulations
talipariti
extract
Prior art date
Application number
ECSENADI202246581A
Other languages
English (en)
Inventor
YAQUIS Alejandro Sa?l PADR?N
D?AZ Jacqueline Aylema ROMERO
Peguero Yanay Montano
Sanchez Jeney Ramirez
Blanco Loraine Licet Infante
Sarmiento Maydel Barrios
Figueredo Yanier N??Ez
Guerra Maylin Wong
Fonseca Luis Arturo Fonseca
Original Assignee
Centro De Investigaci?N Y Desarrollo De Medicamentos Cidem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investigaci?N Y Desarrollo De Medicamentos Cidem filed Critical Centro De Investigaci?N Y Desarrollo De Medicamentos Cidem
Publication of ECSP22046581A publication Critical patent/ECSP22046581A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • A61K36/5775Hibiscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/35Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invenci?n se relaciona con el campo de la salud y en especial con el tratamiento de trastornos de memoria. La invenci?n consiste en la elaboraci?n de formulaciones farmac?uticas orales a partir de un extracto de flavonoides obtenido de la especie Talipairti elatum Sw, que act?a mejorando los diferentes tipos de memoria, tanto a corto como largo plazo asociado con diferentes patolog?as y con el envejecimiento poblacional en humanos.
ECSENADI202246581A 2019-11-14 2022-06-09 Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento ECSP22046581A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2019000091A CU20190091A7 (es) 2019-11-14 2019-11-14 FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.

Publications (1)

Publication Number Publication Date
ECSP22046581A true ECSP22046581A (es) 2022-08-31

Family

ID=76328721

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202246581A ECSP22046581A (es) 2019-11-14 2022-06-09 Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento

Country Status (7)

Country Link
US (1) US20240123008A1 (es)
BR (1) BR112022009475A2 (es)
CA (1) CA3161432A1 (es)
CU (1) CU20190091A7 (es)
EC (1) ECSP22046581A (es)
MX (1) MX2022005877A (es)
WO (1) WO2021121443A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101360109B1 (ko) * 2011-11-30 2014-02-12 대한민국 (식품의약품안전처장) 스피노신을 포함하는 인지기능 장애 질환 예방 또는 치료용 약학조성물
AU2018360383A1 (en) * 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Also Published As

Publication number Publication date
WO2021121443A3 (es) 2022-01-06
CU20190091A7 (es) 2021-06-08
BR112022009475A2 (pt) 2022-07-26
US20240123008A1 (en) 2024-04-18
WO2021121443A2 (es) 2021-06-24
MX2022005877A (es) 2022-06-14
CA3161432A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
MX2022012374A (es) Composiciones multi-suplementos.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CL2018003432A1 (es) Uso de indazoles sustituidos para el tratamiento y la prevención de enfermedades en animales.
EP3445356A4 (en) FAST PLANT-BASED MEDICAL CONNECTIONS AND FOOD SUPPLEMENTS
MA55027A (fr) Formulations plaisante au goût
MX393928B (es) Composiciones alergénicas mixtas y métodos de uso de las mismas.
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
EP4167937A4 (en) PROBIOTIC SKIN FORMULATIONS
CU20210077A7 (es) Extractos bacterianos estables como fármacos
CL2018000525A1 (es) Derivados de espinosina y métodos de preparación.
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
GT200500378A (es) Macrolidos
MX2022001723A (es) Formulaciones de cannabidiol (cbd) y usos de las mismas.
AR101673A1 (es) Composición para el tratamiento de neuropatías y del dolor neuropático
ECSP22046581A (es) Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento
MX2018007128A (es) Composiciones para barnices dentales y metodos para su elaboracion y uso.
CL2020002519A1 (es) Composiciones de erenumab y usos de las mismas
EP4099999C0 (en) DOCETAXEL FORMULATIONS
EP4057941A4 (en) Stable formulations of silk-derived protein
ES2422423T3 (es) Usos cosméticos y farmacéuticos de un extracto de las semillas de Buchholzia coriacea
GT201400115A (es) Combinación farmacéutica antineurítica y composición
MX2018009392A (es) Extracto de lupulo estable a la luz.
GB2550750A (en) Anthelmintic compounds
EP4216945A4 (en) Formulations comprising botanical extracts
CL2022001085A1 (es) Formulación de anticuerpo que contiene crizanlizumab